Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Thomas G. Knight, MD, Myra Robinson, MS, Jing Ai, MD PhD, Brittany K Ragon, MD, Rhonda Davis, RN, BSN, Cindy Shiflett, LPN, Erica Ruston, RN, BSN, Hailey Glover, RN, BSN, Jigar Trivedi, MSc, PharmD, Belinda R Avalos, MD, Jonathan M. Gerber, MD, James T Symanowski, PhD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 2099.

https://doi.org/10.1182/blood-2019-128858

Published: 2019

Journal Articles

Survival and Time to Response with Frontline Hypomethylating Agents in AML

Jing Ai, MD, Danielle Boselli, MS, Lauren M. Bohannon, Thomas G. Knight, MD, Brittany Ragon, MD, Belinda Rene Avalos, MD, Edward A. Copelan, MD, James T Symanowski, PhD, Jonathan M. Gerber, MD, Michael R. Grunwald, MD

Blood (2018) 132 (Supplement 1): 4035.

https://doi.org/10.1182/blood-2018-99-119463

Published: 2018

Journal Articles

Patient Reported Financial Toxicity in Acute Leukemia

Thomas G. Knight, MD, Myra Robinson, MS, Michael R. Grunwald, MD, Lauren M. Bohannon, Erin Blackwell, RN, BSN, OCN, Jing Ai, MD, Brittany Ragon, MD, Rhonda Davis, BSN, RN, Cindy Shiflett, LPN, Erica Ruston, RN, BSN, Jigar Trivedi, MSc, PharmD, Justin Arnall, PharmD, CPP, BCOP, Belinda Rene Avalos, MD, James T Symanowski, PhD, Edward A. Copelan, MD, Jonathan M. Gerber, MD

Blood (2018) 132 (Supplement 1): 4796.

https://doi.org/10.1182/blood-2018-99-119163

Published: 2018

Journal Articles

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Blood (2017) 130 (Supplement 1): 5667.

https://doi.org/10.1182/blood.V130.Suppl_1.5667.5667

Published: 2017

Journal Articles

AcDVP16 Induction Therapy for Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Amy M. Ellenburg, PharmD, Michael Keith Allister Zimmerman, MS, Jing Ai, MD PhD, Thomas G. Knight, MD, Lauren M. Bohannon, Danielle Boselli, MS, Jigar Trivedi, MSc, PharmD, Margaret A. Croom, PharmD, William E. Anderson, JD, MS, James T Symanowski, PhD, Edward A Copelan, MD, Dragos Plesca, PharmD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3902.

https://doi.org/10.1182/blood.V130.Suppl_1.3902.3902

Published: 2017

Journal Articles

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Michael Keith Allister Zimmerman, MS, Danielle Boselli, MS, Lauren M. Bohannon, Myra M Robinson, MSPH, Daniel T. Peters, Jing Ai, MD PhD, Thomas G. Knight, MD, Jigar Trivedi, MSc, PharmD, Dragos Plesca, PharmD, James T Symanowski, PhD, Edward A Copelan, MD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3864.

https://doi.org/10.1182/blood.V130.Suppl_1.3864.3864

Published: 2017

Journal Articles

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

Blood (2017) 130 (Supplement 1): 4605.

https://doi.org/10.1182/blood.V130.Suppl_1.4605.4605

Published: 2017

Journal Articles

A Novel Approach to Identify a Putative Leukemia Stem Cell Population in Acute Lymphocytic Leukemia (ALL) and Distinguish Philadelphia Chromosome-Positive ALL from Lymphoid Blast Crisis Chronic Myeloid Leukemia

Jonathan M. Gerber, MD, Lawrence J. Druhan, PhD, David Foureau, PhD, Elizabeth Jandrisevits, Amanda Lance, BS, Andrea E. Price, BS, Virginia Thurston, PhD, Jing Ai, MD PhD, Michael R. Grunwald, MD, Edward H. Lipford, MD, Belinda R. Avalos, MD

Blood (2016) 128 (22): 2912.

https://doi.org/10.1182/blood.V128.22.2912.2912

Published: 2016

Journal Articles

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 2793.

https://doi.org/10.1182/blood.V128.22.2793.2793

Published: 2016

Journal Articles

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplantation Program

Edward A. Copelan, MD FACP, Jonathan M. Gerber, MD, Saad Z Usmani, MD FACP, Michael R. Grunwald, MD, Nilanjan Ghosh, MD PhD, Omotayo O. Fasan, MBBS, MRCP, Manisha Bhutani, MD, James T Symanowski, PhD, Derek Raghavan, MD PhD FACP, FRACP, FASCO, Belinda R. Avalos, MD

Blood (2016) 128 (22): 3580.

https://doi.org/10.1182/blood.V128.22.3580.3580

Published: 2016

Journal Articles

Aldehyde Dehydrogenase Activity in the Leukemic Stem Cell Compartment Uncovers Opposing Methylation Patterns of Leukemia Stem Cells in AML

Lauren Suarez, Tingting Qin, PhD, Kristen Meldi, PhD, Manjusha Thakar, Sarah Sakoian, Gabriel Ghiaur, MD PhD, Jonathan M. Gerber, MD, Hetty E. Carraway, MD MBA, Maria E Figueroa, MD, Steven D. Gore, MD

Blood (2016) 128 (22): 3925.

https://doi.org/10.1182/blood.V128.22.3925.3925

Published: 2016

Journal Articles

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 1622.

https://doi.org/10.1182/blood.V128.22.1622.1622

Published: 2016

Journal Articles

Next-Generation Bisulfite Sequencing of Aml Reveals Widespread Acquisition of Epigenetic Abnormalities in Leukemic Stem Cells That Are Stably Retained in More Mature Leukemic Cell Fractions

Lauren Suarez, Tingting Qin, PhD, Kristen Meldi, PhD, Manjusha Thakar, Sarah Sakoian, Jonathan M. Gerber, MD, Gabriel Ghiaur, MD PhD, Hetty E. Carraway, MD MBA, Maria E Figueroa, MD, Steven D. Gore, MD

Blood (2015) 126 (23): 2429.

https://doi.org/10.1182/blood.V126.23.2429.2429

Published: 2015

Journal Articles

The JAK2 V617F Stem Cell Burden Is Mosaic, Dynamic and Correlates with Clinical Disease Burden in the MPN: An Exploitable Target

Alison R Moliterno, MD, Donna Marie Williams, PhD, Jonathan M. Gerber, MD, Michael A McDevitt, MD PhD, Ophelia Rogers, Jerry L. Spivak, MD

Blood (2015) 126 (23): 4090.

https://doi.org/10.1182/blood.V126.23.4090.4090

Published: 2015

Journal Articles

Congenital Neutrophilia Arising from a T618I Germline Mutation in the CSF3R Gene

Daniel P McMahon, MD, Amanda Lance, BS, Andrea E. Price, BS, Jonathan M. Gerber, MD, Sarah A Baxter, PhD, Lawrence J Druhan, PhD, Nury M Steuerwald, PhD, Belinda R Avalos, MD

Blood (2015) 126 (23): 1623.

https://doi.org/10.1182/blood.V126.23.1623.1623

Published: 2015

Journal Articles

Single Cell Analysis Of JAK2 V617F Positive MPN Stem/Progenitor Cells In Chronic Phase and Leukemic Transformation

Jonathan M. Gerber, MD, Donna M. Williams, PhD, Ophelia Rogers, Sarah Morse, Hao Zhang, Michael A McDevitt, MD, PhD, Richard J. Jones, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2013) 122 (21): 1609.

https://doi.org/10.1182/blood.V122.21.1609.1609

Published: 2013

Journal Articles

Polycythemia Vera: Redefinition in the Genomic Era

Alison R. Moliterno, MD, Donna M. Williams, PhD, Michael A McDevitt, MD, PhD, Brady L Stein, MD, Jonathan M. Gerber, MD, Ophelia Rogers, Michael B. Streiff, MD, Sophie Lanzkron, M.D., Linda Resar, M.D., Christine O'Keefe, PhD, Jaroslaw P. Maciejewski, MD, PhD, Jerry L. Spivak, MD

Blood (2012) 120 (21): 1754.

https://doi.org/10.1182/blood.V120.21.1754.1754

Published: 2012

Journal Articles

Randomized Phase II Trial of Timed-Sequential Therapy (TST) with Flavopiridol (Alvocidib), Ara-C and Mitoxantrone (FLAM) Versus “7+3” for Adults Ages 70 Years and Under with Newly Diagnosed Acute Myeloid Leukemia (AML)

Joshua F. Zeidner, MD, Jonathan M. Gerber, MD, Amanda Blackford, Mark Litzow, MD, Matthew C. Foster, MD, Lawrence E. Morris, Jr., MD, Ivana Gojo, MD, Jeffrey E. Lancet, MD, Prithviraj Bose, MD, Raoul Tibes, MD, Stephen A. Strickland, MD, MSCI, Jacqueline M Greer, RN, Michelle Drye, Kevin Meads, Austin Doyle, MD, Richard F Little, MD, MPH, John J Wright, MD, PhD, Judith E. Karp, MD

Blood (2012) 120 (21): 47.

https://doi.org/10.1182/blood.V120.21.47.47

Published: 2012

Journal Articles

The Clinical Relevance of Acute Myeloid Leukemia Stem Cells

Jonathan M. Gerber, MD, B. Douglas Smith, MD, Brownhilda Ngwang, Hao Zhang, Milada Vala, Laura Morsberger, Steven Galkin, Michael Collector, Brandy Perkins, Mark J. Levis, MD, PhD, Constance Griffin, M.D., Saul J. Sharkis, PhD, Michael J. Borowitz, MD, PhD, Judith E. Karp, MD, Richard J. Jones, MD

Blood (2011) 118 (21): 240.

https://doi.org/10.1182/blood.V118.21.240.240

Published: 2011

Journal Articles

The Leukemic Stem Cell in Polycythemia Vera and Primary Myelofibrosis Is Distinct From the Initiating JAK2 V617F-Positive Hematopoiertic Stem Cell

Jonathan M. Gerber, MD, Brownhilda Ngwang, Hao Zhang, Donna M. Williams, PhD, Ophelia Rogers, Richard J. Jones, Alison R. Moliterno, MD, Jerry L. Spivak, MD

Blood (2011) 118 (21): 613.

https://doi.org/10.1182/blood.V118.21.613.613

Published: 2011

NARROW

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Survival and Time to Response with Frontline Hypomethylating Agents in AML

Patient Reported Financial Toxicity in Acute Leukemia

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

AcDVP16 Induction Therapy for Acute Myeloid Leukemia

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

A Novel Approach to Identify a Putative Leukemia Stem Cell Population in Acute Lymphocytic Leukemia (ALL) and Distinguish Philadelphia Chromosome-Positive ALL from Lymphoid Blast Crisis Chronic Myeloid Leukemia

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplantation Program

Aldehyde Dehydrogenase Activity in the Leukemic Stem Cell Compartment Uncovers Opposing Methylation Patterns of Leukemia Stem Cells in AML

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Next-Generation Bisulfite Sequencing of Aml Reveals Widespread Acquisition of Epigenetic Abnormalities in Leukemic Stem Cells That Are Stably Retained in More Mature Leukemic Cell Fractions

The JAK2 V617F Stem Cell Burden Is Mosaic, Dynamic and Correlates with Clinical Disease Burden in the MPN: An Exploitable Target

Congenital Neutrophilia Arising from a T618I Germline Mutation in the CSF3R Gene

Single Cell Analysis Of JAK2 V617F Positive MPN Stem/Progenitor Cells In Chronic Phase and Leukemic Transformation

Polycythemia Vera: Redefinition in the Genomic Era

Randomized Phase II Trial of Timed-Sequential Therapy (TST) with Flavopiridol (Alvocidib), Ara-C and Mitoxantrone (FLAM) Versus “7+3” for Adults Ages 70 Years and Under with Newly Diagnosed Acute Myeloid Leukemia (AML)

The Clinical Relevance of Acute Myeloid Leukemia Stem Cells

The Leukemic Stem Cell in Polycythemia Vera and Primary Myelofibrosis Is Distinct From the Initiating JAK2 V617F-Positive Hematopoiertic Stem Cell

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only